Explore more publications!

Health Observer Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.

Press releases published on November 18, 2025

Catheter Precision Announces Third VIVO Installation in France
Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
Sisters in Birth Launches Capital Campaign to Build Birth Centers in Mississippi
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
QHSLab (OTCQB:USAQ) Completes Repurchase of Legacy Debt, Enhancing Capital Structure, Strengthening Balance Sheet and Reducing Future Dilution
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease
Forced from Home for the Holidays: Medical Teams International Gifts Provide Life-Saving Healthcare to People in Crisis-Affected Communities
Aurora Spine Corporation Announces Record Third Quarter Financial Results
24/7 Market News- Kraig Biocraft Laboratories Receives Spider Silk Order from Global Performance Sports Brand, Marking Several Major Milestones
EDAP to Present at Piper Sandler 37th Annual Healthcare Conference
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals
Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson
Aiomics Supports Independent Research at Charité to Advance Evidence-Based Clinical Documentation

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions